3 completed, 2 recruiting, 1 terminated, 1 unknown. 3 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 2 | Completed 1, Terminated 1 |
Follow Factor Xa Inhibitors: new trials by email Literature Review of Factor Xa Inhibitors trials Research Report on Factor Xa Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage Direct-Acting Oral Anticoagulants (used as per local standard practice) - Traumatic Intracranial Haemorrhage | Phase 3 | Recruiting | Walton Centre NHS Foundation Trust | 1084 | 2025-03-10 | 2026-06-18 |
| PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years Transcatheter PFO closure, Oral Anticoagulant, Direct-Acting, Antiplatelet therapy - Cryptogenic Ischemic Stroke, Patent Foramen Ovale | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 792 | 2023-07-07 | 2026-03-24 |
| Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction Oral Anticoagulant, Direct-Acting - Pharmacogenetics, Drug-Related Side Effects and Adverse Reactions | Unknown | Clinical Hospital Centre Zagreb | 1200 | 2020-12-15 | 2022-04-01 | |
| Perioperative Management of Factor Xa Inhibitors Factor Xa Inhibitor - Atrial Fibrillation, Anticoagulant-induced Bleeding | Not applicable | Completed | Seoul National University Hospital | 2500 | 2020-08-04 | 2026-08-21 |
| Mild Head Injury, Antiplatelets, and Anticoagulants direct anticoagulant, antiplatelet drugs, Dicumarols - Craniocerebral Trauma, Cerebral Hemorrhage | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2127 | 2019-09-27 | 2022-03-31 | |
| Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis Apixaban, Standard of care - Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 1510 | 2016-08-26 | 2021-02-25 |
| Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation Drug (Direct thrombin or Factor Xa inhibitor) - Atrial Fibrillation | Not applicable | Terminated | Abbott Medical Devices | 64 | 2013-01-01 | 2020-08-13 |
Atrial Fibrillation (2) · Aortic Valve Stenosis (1) · Cerebral Hemorrhage (1) · Cerebral Hemorrhage, Traumatic (1) · Craniocerebral Trauma (1) · Drug-Related Side Effects and Adverse Reactions (1) · Foramen Ovale, Patent (1) · Intracranial Hemorrhage, Traumatic (1) · Ischemic Stroke (1)
Assistance Publique - Hôpitaux de Paris (2) · Abbott Medical Devices (1) · Clinical Hospital Centre Zagreb (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Seoul National University Hospital (1) · Walton Centre NHS Foundation Trust (1)
France (2) · Italy (2) · Croatia (1) · Germany (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)
Catherine McMahon (1) · Eue-Keun Choi, MD, PhD (1) · Gilles Chatellier, MD (1) · Jean-Louis Mas, MD (1) · Marcello Candelli, MD, PhD (1) · Peter Zimetbaum, MD (1) · Tamara Bozina, PhD (1)
PMID 29536857, PMID 29898848, PMID 35583186, PMID 36137682, PMID 38774425, PMID 41520206, PMID 42754280
2015 (1)